№ files_lp_4_process_3_083681
File format: docx
Character count: 4387
File size: 18 KB
This document is a research study comparing the presence of Chlamydia trachomatis among healthy women and women suffering from infertility in Ghana, exploring the association between the infection and infertility in a developing country context.
Year:
2013
Region / City:
Ghana, West Africa
Topic:
Health / Infectious Diseases / Infertility
Document Type:
Research Study
Organization:
Not specified
Author:
Katie Busenbark
Target Audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / city:
Europe
Theme:
Sexually transmitted infections, Chlamydia trachomatis
Document type:
Guideline
Organization:
European Health Institutions
Author:
John A White, Nicole HTM Dukers-Muijrers, Christian JPA Hoebe, Chris R Kenyon, Jonathan DC Ross, Magnus Unemo
Target audience:
Healthcare professionals, clinicians
Period of validity:
2024
Approval date:
N/A
Date of modifications:
N/A
Note:
Year
Year:
2022
Region:
Massachusetts
Jurisdiction:
United States
Topic:
Chlamydia infection; expedited partner therapy; sexually transmitted infections
Document type:
Clinical advisory
Issuing body:
Massachusetts Department of Public Health
Legal basis:
M.G.L. c. 111 § 121B; 105 CMR 700.003(J); 105 CMR 721.000
Target audience:
Healthcare providers and pharmacists
Standard treatment referenced:
Doxycycline; azithromycin
Population referenced:
Adolescents, young adults, men who have sex with men
Date of update:
January 28, 2022
Note:
Year
Region / city:
England
Topic:
Chlamydia testing and diagnoses
Document type:
Data request form
Organisation:
CTAD, UKHSA
Author:
Not specified
Target audience:
Organisations involved in sexual health care (NHS, service providers, Department of Health and Social Care, local government, partner organisations)
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2022
Region / city:
Victoria, Australia
Topic:
Chlamydia treatment
Document type:
Official FAQ
Organization:
Victorian Government, Department of Health
Author:
Victorian Government
Target audience:
Patients diagnosed with chlamydia and their sexual partners
Period of validity:
N/A
Approval date:
June 2022
Date of last modification:
N/A
Note:
Year
Theme:
Microbiological diagnostics, Rickettsial infections, Chlamydia, Mycoplasma
Document type:
Educational material
Target audience:
Students, medical professionals
Contextual description:
A medical educational document focusing on the microbiological diagnostics of infections caused by rickettsia, chlamydia, and mycoplasma, detailing the properties, transmission, pathogenesis, clinical findings, and laboratory diagnosis of these infections.
Year:
2024
Region / city:
Europe
Theme:
Sexually transmitted infections, Chlamydia trachomatis
Document type:
Guideline
Organization:
European Health Institutions
Author:
John A White, Nicole HTM Dukers-Muijrers, Christian JPA Hoebe, Chris R Kenyon, Jonathan DC Ross, Magnus Unemo
Target audience:
Healthcare professionals, clinicians
Period of validity:
2024
Approval date:
N/A
Date of modifications:
N/A
Year:
2024
Institution:
Utrecht University; Wageningen University & Research
Type:
Master of Science research project
Supervisor:
Dr. Y.R.A. van Zeeland; Dr. R. Gehring; Dr. M. Heijne
Student:
T. Ploegers
Study period:
August 2019 – August 2020
Species studied:
Budgerigars and other avian species
Sample types:
Fecal and serum samples
Treatment methods:
Oral and intramuscular doxycycline
Objective:
Investigate residual excretion and pharmacokinetics of doxycycline
Ethical approval:
License AVD1080020184847 by CCD for university-collected samples
Source of field cases:
Dutch Food and Consumer Product Safety Authority (NVWA)
Version:
Final
Date:
August 4, 2024
Scope:
Zoonotic disease psittacosis, avian pharmacokinetics
Year:
2023
Region / City:
California, USA
Topic:
Health Reimbursement Arrangement for Infertility Care
Document Type:
Plan Summary Description
Organization:
The Regents of the University of California
Author:
The Regents of the University of California
Target Audience:
Eligible employees and qualified beneficiaries of the University of California
Period of Coverage:
March 1, 2023 - December 31, 2023
Date of Approval:
March 1, 2023
Date of Last Modification:
N/A
Year:
2024
Region / City:
Kwara State, Nigeria
Document Type:
Research Paper
Organization / Institution:
University of Ilorin, Department of Health Promotion & Environmental Health Education
Target Audience:
Researchers, Healthcare Professionals, Policy Makers
Period of Effect:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2022
Region / City:
South Western Uganda
Topic:
Infertility
Document Type:
Research Study
Institution:
Mbarara Regional Referral Hospital
Author:
Tumusiime Mathew
Target Audience:
Healthcare professionals, Researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Methodology:
Cross-sectional study
Sample Size:
427 participants
Key Findings:
Age above 34 and irregular menstrual cycles associated with infertility
Context:
A research study examining the prevalence of infertility and associated factors among women in a gynecology clinic in Uganda
Year:
2026
Region / State:
West Virginia
Document Type:
Legislative Fiscal Note
Subject:
Health Insurance, Infertility Treatment
Legislative Body:
West Virginia Legislature
Introduced by:
Delegate Young
Date Introduced:
February 3, 2026
Committee Referral:
Health and Human Resources, then Finance
Target Audience:
Health insurers, policymakers, residents seeking fertility services
Related Legislation:
House Bill 5141
Effective Date:
Upon enactment
Definitions Included:
Yes – infertility, fertility treatment, medically necessary, standard fertility preservation services
Coverage Requirements:
Diagnosis, fertility treatment, fertility preservation for medical procedures impacting fertility
Prohibited Limitations:
Deductibles, copayments, preexisting condition exclusions, arbitrary limits on coverage
Year:
2026
Region / City:
Belagavi, India
Subject:
Pharmacology, Male Fertility, Herbal Extracts
Document Type:
Research Supplementary Material
Institution:
KLE College of Pharmacy, KLE Academy of Higher Education and Research (KAHER)
Authors:
Prakash R. Biradar, Ashwini Karade
Target Audience:
Researchers in pharmacology and reproductive biology
Experimental Model:
Male Wistar rats (200-250g)
Treatment Period:
30 days
Extract Dosage:
150 mg/kg, 300 mg/kg, 600 mg/kg
Parameters Measured:
Sexual behavior, semen parameters, body weight, GSI, hematological parameters, organ weights, antioxidant markers (GSH, SOD, MDA), histopathology
Analysis Methods:
In vivo experimental study, biochemical assays, histopathology, statistical significance testing
Corresponding Author Email:
[email protected]